<

 
Data updated 2025-04-25 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date16711533.6 (espacenet)  (Federated)  (European Patent Register), 20160210
Patent/reg. no. and dateDK/EP 3256162, 20231206
Publication date20171220
Priority no. and dateEP 15154629, 20150211
EP pub. no. and date EP 3256162 20171220
Effective date
Applicant/ownerDeutsches Krebsforschungszentrum, Im Neuenheimer Feld 280
69120 Heidelberg , DE,
Ruprecht-Karls-Universität, Grabengasse 1
69117 Heidelberg, DE
Applicant ref. no.PV1840DKEP
InventorROMMELAERE, Jean, Schloss-Wolfsbrunnenweg 11
69118 Heidelberg, DE,
GELETNEKY, Karsten, Beethoven-Str. 35
69121 Heidelberg, DE,
WICK, Wolfgang, Schloss-Wolfsbrunnenweg 1
69117 Heidelberg, DE,
WICK, Antje, Schloss-Wolfsbrunnenweg 1
69117 Heidelberg, DE,
DAHM, Michael, Saalestr. 5
81677 München, DE
RepresentativePatrade A/S, Ceresbyen 75, 8000 Århus C
Opponent
IPC ClassA61K 35/768 (2015.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/22 (2006.01) 
TitleKRÆFTBEHANDLING MED EN PARVOVIRUS KOMBINERET MED BEVACIZUMAB
Int. application no.EP2016025008
Int. publication no.WO2016128146
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact